Lv7
3390 积分 2021-06-03 加入
PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial
5天前
已完结
CAR T-cells in autoimmunity: game changer or stepping stone?
5天前
已关闭
Leucine zipper-based immunomagnetic purification of CAR T cells displaying multiple receptors
5天前
已完结
FAS-less allogeneic CAR T cells
5天前
已完结
Phase I Trial of MCARH109, a G Protein–Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
22天前
已完结
Treatment of CNS systemic lupus erythematosus with CD19 CAR T cells
22天前
已完结
Ablation of FAS confers allogeneic CD3– CAR T cells with resistance to rejection by T cells and natural killer cells
1个月前
已完结
Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy
1个月前
已完结
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
1个月前
已完结
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
1个月前
已完结
皖公网安备34019202002308
